早期改善在抗抑郁药治疗重度抑郁症(MDD)中的研究进展

 在第2周未达到早期改善(early improvement)的重度抑郁症(major depressive disorder,MDD)患者继续维持原治疗方案只有3%能达到临床治愈,但尽管早期改善有较高的阴性预测值,阳性预测值却不理想。本综述整理现有的研究中除了17项汉密尔顿抑郁量表总分的减分率外,还有哪些指标能判断早期改善,早期改善的预测效果受到什么因素影响,能否协同这些因素提高早期改善的预测效果。用以指导早期换药,降低患者接受无效治疗的时间,降低治疗费用,增加患者对治疗的信心。

Advances in early improvement of antidepressants for treating major depressive disorder (MDD)

 Early improvement in the first 2 weeks can only predict 3% non-remission in major depressive disorder (MDD) patients who continued the original treatment.However,the positive predictive value of early improvement was unsatisfactory despite of higher negative predictive value.This report provides an updated review about the indicators of early improvement and the influence factor of the predictive value of early improvement.